2016
DOI: 10.1007/s10719-016-9663-5
|View full text |Cite
|
Sign up to set email alerts
|

A case for protein-level and site-level specificity in glycoproteomic studies of disease

Abstract: Abnormal glycosylation of proteins is known to be either resultant or causative of a variety of diseases. This makes glycoproteins appealing targets as potential biomarkers and focal points of molecular studies on the development and progression of human ailment. To date, a majority of efforts in disease glycoproteomics have tended to center on either determining the concentration of a given glycoprotein, or on profiling the total population of glycans released from a mixture of glycoproteins. While these appr… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
13
0

Year Published

2017
2017
2024
2024

Publication Types

Select...
7
1

Relationship

3
5

Authors

Journals

citations
Cited by 10 publications
(13 citation statements)
references
References 70 publications
0
13
0
Order By: Relevance
“…14 Consequently, the glycosylation status of proteins has garnered significant attention from the standpoint of human health and disease. 57 In this context, anomalous modes of protein glycosylation may be predictive or indicative of a given disease state, as well documented in many forms of cancer. 810 Alternatively, defects of protein glycosylation may serve to trigger a given disease state, such as in the various congenital disorders of glycosylation.…”
Section: Introductionmentioning
confidence: 99%
“…14 Consequently, the glycosylation status of proteins has garnered significant attention from the standpoint of human health and disease. 57 In this context, anomalous modes of protein glycosylation may be predictive or indicative of a given disease state, as well documented in many forms of cancer. 810 Alternatively, defects of protein glycosylation may serve to trigger a given disease state, such as in the various congenital disorders of glycosylation.…”
Section: Introductionmentioning
confidence: 99%
“…Protein glycosylation is a common post-translational modification, and differential protein glycosylation has been identified as a characteristic of many common diseases. , Hence, there is active interest in the development and application of analytical techniques aimed to monitor protein glycosylation. Glycan analysis at the site- and protein-specific level remains difficult, because identification of both the peptide moiety and the glycan is necessary . This is even more prominent for analyses in a high-throughput manner, which are often necessary in biomedical research involving large numbers of patient samples.…”
Section: Introductionmentioning
confidence: 99%
“…Glycan analysis at the site-and protein-specific level remains difficult, because identification of both the peptide moiety and the glycan is necessary. 3 This is even more prominent for analyses in a high-throughput manner, which are often necessary in biomedical research involving large numbers of patient samples. Common analytical strategies involve either release of the glycans directly from all proteins in the tissue (e.g., refs 4,5 ) or glycan-or glycopeptide analysis of individual proteins purified from biological samples (e.g., refs 6,7 ).…”
Section: ■ Introductionmentioning
confidence: 99%
“…glycopeptides), which are typically analyzed as protonated ions, tandem MS is incapable of providing full information on the branching pattern, linkage information, or stereochemistry of the glycan 11 . Understanding glycobiology at the highest level of detail, including site-specific localization of all glycan structural isomers within glycoproteins 12 , will necessitate a thorough understanding of the properties of carbohydrate fragment ions.…”
Section: Introductionmentioning
confidence: 99%